Capricor Therapeutics CAPR Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's return on invested capital?
- Capricor Therapeutics (CAPR) reported return on invested capital of -83.2% in Q1 2026.
- How has Capricor Therapeutics's return on invested capital changed year-over-year?
- Capricor Therapeutics's return on invested capital increased by 14.5% year-over-year, from -97.3% to -83.2%.
- What is the long-term trend for Capricor Therapeutics's return on invested capital?
- Over 3 years (2022 to 2025), Capricor Therapeutics's return on invested capital has grown at a -39.0% compound annual growth rate (CAGR), from -566.3% to -128.7%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.